Compare DVA & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVA | ENSG |
|---|---|---|
| Founded | 1994 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 11.6B |
| IPO Year | 2002 | 2007 |
| Metric | DVA | ENSG |
|---|---|---|
| Price | $149.94 | $198.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $156.75 | ★ $202.60 |
| AVG Volume (30 Days) | ★ 724.0K | 314.4K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.13% |
| EPS Growth | N/A | ★ 14.06 |
| EPS | ★ 9.84 | 5.84 |
| Revenue | ★ $13,643,069,000.00 | $5,057,841,000.00 |
| Revenue This Year | $3.85 | $17.07 |
| Revenue Next Year | $3.07 | $9.49 |
| P/E Ratio | ★ $15.32 | $34.52 |
| Revenue Growth | 6.46 | ★ 18.72 |
| 52 Week Low | $101.00 | $118.73 |
| 52 Week High | $159.42 | $218.00 |
| Indicator | DVA | ENSG |
|---|---|---|
| Relative Strength Index (RSI) | 50.72 | 43.96 |
| Support Level | $146.05 | $173.15 |
| Resistance Level | $152.31 | $215.95 |
| Average True Range (ATR) | 3.54 | 4.35 |
| MACD | -0.85 | -0.38 |
| Stochastic Oscillator | 42.07 | 44.03 |
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.